Skip to main content

The Use of Hormonal Contraception and Its Impact on Women’s Moods

  • Chapter
  • First Online:
Women's Reproductive Mental Health Across the Lifespan
  • 1947 Accesses

Abstract

It is commonly believed that hormonal contraception has significant effects on a woman’s mood. However this belief has not been well substantiated and the literature is replete with conflicting data. Inconsistent research findings echo the frequent clinical observation that patients experience disparate reactions to hormonal contraception, making it challenging to medically manage and counsel patients in their use of hormonal contraception in regard to their mental health. The relationship between exogenous hormones and mood disorders has not been studied in sufficient depth to provide a definitive answer to the question of whether these hormones have a direct effect on clinical psychiatric outcomes. This chapter will guide clinicians towards making the best contraceptive choices for their patients who have, or are at risk for developing, mood and anxiety disorders. This chapter will review the neurobiological basis for the interaction between exogenous hormones and mood; outline the indications, risks, and common side effects of currently available hormonal contraceptives; and review the scientific literature to guide recommendations for identifying the ideal contraceptive method for a given patient in a patient-centered, individualized process that accounts for their mental health history.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abou-Setta, A. M., Houston, B., Al-Inany, H. G., & Farquhar, C. (2013). Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. The Cochrane Database of Systematic Reviews, 31(1), CD005072.

    Google Scholar 

  • Almagor, M., & Ben-Porath, Y. S. (1991). Mood changes during the menstrual cycle and their relation to the use of oral contraceptive. Journal of Psychosomatic Research, 35(6), 721–728.

    Article  Google Scholar 

  • American College of Obstetricians and Gynecologists. (2011). ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and Intrauterine Devices. Obstetrics and Gynecology, 105, 223–232.

    Article  Google Scholar 

  • Ben Dor, R., Harsh, V. L., Fortinsky, P., Koziol, D. E., Rubinow, D. R., & Schmidt, P. J. (2013). Effects of pharmacologically induced hypogonadism on mood and behavior in healthy young women. American Journal of Psychiatry, 170(4), 426–433.

    Article  Google Scholar 

  • Berenson, A. B., Asem, H., Tan, A., & Wilkinson, G. (2011). Continuation rates and complications of intrauterine contraception in women diagnosed with bipolar disorder. Obstetrics and Gynecology, 118(6), 1331–1336.

    Article  Google Scholar 

  • Blehar, M. C., Depaulo, J. R., Gershon, E. S., Reich, T., Simpson, S. G., & Nurnberger, J. I. (1998). Women with bipolar disorder: Findings from the NIMH genetics initiative sample. Psychopharmacology Bulletin, 34, 239–243.

    Google Scholar 

  • Bloch, M., Daly, R. C., & Rubinow, D. R. (2003). Endocrine factors in the etiology of postpartum depression. Comprehensive Psychiatry, 44(3), 234–246.

    Article  Google Scholar 

  • Bloch, M., Rubinow, D. R., Schmidt, P. J., Lotsikas, A., Chrousos, G. P., & Cizza, G. (2005). Cortisol responses to ovine corticotropin-resealing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. Journal of Clinical Endocrinology and Metabolism, 90, 924–930.

    Article  Google Scholar 

  • Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000). Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry, 157(6), 924–930.

    Article  Google Scholar 

  • Borenstein, J., Yu, H. T., Wade, S., Chiou, C. F., & Rapkin, A. (2003). Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life. The Journal of Reproductive Medicine, 48(2), 79–85.

    Google Scholar 

  • Brummelte, S., & Galea, L. A. (2010). Depression during pregnancy and postpartum: Contribution of stress and ovarian hormones. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(5), 766–776.

    Article  Google Scholar 

  • Champagne, F. A., Weaver, I. C., Dioro, J., Dymov, S., Szyf, M., & Meaney, M. J. (2006). Maternal care associated with methylation of the estrogen receptor-alpha1b promoter and estrogen receptor-alpha expression in the medial preoptic area of female offspring. Endocrinology, 147, 2909–2915.

    Article  Google Scholar 

  • Cheng, L., Che, Y., & Gülmezoglu, A. M. (2012). Interventions for emergency contraception. The Cochrane Database of Systematic Reviews, 15(8), CD001324.

    Google Scholar 

  • Cyranowski, J. M., Hofkens, T. L., Frank, E., Seltman, H., Cai, H. M., & Amico, J. A. (2008). Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosomatic Medicine, 70(9), 967–975.

    Article  Google Scholar 

  • Dennis, C. L., Ross, L. E., & Herxheimer, A. (2008). Oestrogens and progestins for preventing and treating postpartum depression. The Cochrane Database of Systematic Reviews. (4), CD001690.

    Google Scholar 

  • Endicott, J. (1993). The menstrual cycle and mood disorders. Journal of Affective Disorders, 29(2–3), 193–200.

    Article  Google Scholar 

  • Forrester-Knauss, C., Zemp Stutz, E., Weiss, C., & Tschudin, S. (2011). The interrelation between premenstrual syndrome and major depression: Results from a population-based sample. BMC Public Health, 11, 795.

    Article  Google Scholar 

  • Franklin, T. B., Russig, H., Weiss, I. C., Gräff, J., Linder, N., Michalon, A., … Mansuy, I. M. (2010). Epigenetic transmission of the impact of early stress across generations. Biological Psychiatry. 68, 408–415.

    Google Scholar 

  • Freeman, E. W., Halbreich, U., Grubb, G. S., Rapkin, A. J., Skouby, S. O., Smith, L., … Constantine, G. D. (2012). An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception, 85(5), 437–45.

    Google Scholar 

  • Fritz, M. A., & Speroff, L. (2011). Clinical gynecologic endocrinology and infertility (8th ed., pp. 157–163). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Galea, L. A., Wide, J. K., & Barr, A. M. (2001). Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behavioural Brain Research, 122(1), 1–9.

    Google Scholar 

  • Gregoire, A. J., Kumar, R., Everitt, B., Henderson, A. F., & Studd, J. W. (1996). Transdermal oestrogen for the treatment of severe postnatal depression. Lancet, 347(9006), 930–933.

    Article  Google Scholar 

  • Huber, J. C., Heskamp, M. L., & Schramm, G. A. (2008). Effect of an oral contraceptive with chlormadinone acetate on depressive mood: analysis of data from four observational studies. Clinical Drug Investigation, 28(12), 783–791.

    Article  Google Scholar 

  • Joffe, H., Lee, C., & Harlow, B. (2003). Impact of oral contraceptive pill use on premenstrual mood. Predictors of improvement and deterioration. American Journal of Obstetrics and Gynecology, 189(6), 1523–1530.

    Article  Google Scholar 

  • Joffe, H., Petrillo, L. F., Viguera, A. C., Gottshcall, H., Soares, C. N., Hall, J. E., & Cohen, L. S. (2007). Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report. Journal of Clinical Psychiatry, 68(12), 1954–1962.

    Google Scholar 

  • Karuppaswamy, J., & Vlies, R. (2003). The benefit of oestrogens and progestogens in postnatal depression. Journal of Obstetrics and Gynaecology, 23(4), 341–346.

    Article  Google Scholar 

  • Kulkarni, J., de Castella, A., Fitzgerald, P. B., Gurvich, C. T., Bailey, M., Bartholomeusz, C., & Burger, H. (2008). Estrogen in severe mental illness: A potential new treatment approach. Archives of General Psychiatry, 65, 955–960.

    Google Scholar 

  • Lawrie, T. A., Hofmeyr, G. J., de Jager, M., Berk, M., Paiker, J., & Viljoen, E. (1998). A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: The effect on postnatal depression and serum hormones. British Journal of Obstetrics and Gynaecology, 105, 1082–1090.

    Article  Google Scholar 

  • Lopez, L. M., Edelman, A., Chen, M., Otterness, C., Trussell, J., & Helmerhorst, F. M. (2013). Progestin-only contraceptives: Effects on weight. The Cochrane Database of Systematic Reviews, 2(7), CD008815.

    Google Scholar 

  • Lopez, L. M., Kaptein, A. A., & Helmerhorst, F. M. (2012). Oral contraceptives containing drospirenone for premenstrual syndrome (Review). The Cochrane Database of Systematic Reviews, 15(2), CD006586.

    Google Scholar 

  • Magiakou, M. A., Mastorakos, G., Rabin, D., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1996). Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: Implications for the increase in psychiatric manifestations at this time. Journal of Clinical Endocrinology and Metabolism, 81(5), 1912–1917.

    Google Scholar 

  • Meltzer-Brody, S. (2011). New insights into perinatal depression: Pathogenesis and treatment during pregnancy and postpartum. Dialogues in Clinical Neuroscience, 13(1), 89–100.

    Google Scholar 

  • Muirhead, G. J., Harness, J., Holt, P. R., Oliver, S., & Anziano, R. J. (2000). Ziprasidone and the pharmacokinetics of a combined oral contraceptive. British Journal of Clinical Pharmacology, 49(Suppl. 1), 49S–56S.

    Google Scholar 

  • Nappi, C., Bifulco, G., Tommaselli, G. A., Gargano, V., & Di Carlo, C. (2012). Hormonal contraception and bone metabolism: A systematic review. Contraception, 86(6), 606–621.

    Article  Google Scholar 

  • Nevatte, T., O’Brien, P. M., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., … Consensus Group of the International Society for Premenstrual Disorders. (2013). ISPMD consensus on the management of premenstrual disorders. Archives of Women’s Mental Health, 16(4), 279–291.

    Google Scholar 

  • Oinonen, K. A., & Mazmanian, D. (2002). To what extent do oral contraceptives influence mood and affect? Journal of Affective Disorders, 70(3), 229–240.

    Article  Google Scholar 

  • Pedersen, C., Vadlamudi, S., Boccia, M., & Amico, J. A. (2006). Maternal behavior deficits in nulliparous oxytocin knockout mice. Genes, Brain and Behavior, 5, 274–281.

    Article  Google Scholar 

  • Peterson, H. (2008). Sterilization. Obstetrics and Gynecology, 111(1), 189–203.

    Article  Google Scholar 

  • Pincus, S., Alam, S., Rubinow, D. R., Bhuvaneswar, C. G., & Schmidt, P. J. (2011). Predicting response to leuprolide of women with premenstrual dysphoric disorder by daily mood rating dynamics. Journal of Psychiatric Research, 45(3), 386–394.

    Article  Google Scholar 

  • Purba, J., Hoogendijk, W., Hofman, M., & Swaab, D. F. (1996). Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Archives of General Psychiatry, 52, 137–143.

    Article  Google Scholar 

  • Rasgon, N., Bauer, M., Glenn, T., Elman, S., & Whybrow, P. C. (2003). Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disorder, 5(1), 48–52.

    Article  Google Scholar 

  • Riecher-Rössler, A. (2002). Oestrogen effects in schizophrenia and their potential therapeutic implications—review. Archives of Women’s Mental Health, 5, 111–118.

    Article  Google Scholar 

  • Ryan, J., & Ancelin, M. L. (2012). Polymorphisms of estrogen receptors and risk of depression: Therapeutic implications. Drugs, 72(13), 1725–1738.

    Article  Google Scholar 

  • Scarselli, G., Bargelli, G., Taddei, G. L., Marchionni, M., Peruzzi, E., Pieralli, A., … Fambrini, M. (2011). Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: A 15-year follow-up study. Fertility and Sterility, 95, 420.

    Google Scholar 

  • Schiller, C. E., O’Hara, M. W., Rubinow, D. R., & Johnson, A. K. (2013). Estradiol modulates anhedonia and behavioral despair in rats and negative affect in a subgroup of women at high risk for postpartum depression. Physiology and Behavior, 119, 137–144.

    Article  Google Scholar 

  • Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine, 338, 209–216.

    Article  Google Scholar 

  • Seeman, M., & Ross, R. (2011). Prescribing contraceptives for women with schizophrenia. Journal of Psychiatric Practice, 17(4), 258–269.

    Article  Google Scholar 

  • Segebladh, B., Borgström, A., Odlind, V., Bixo, M., & Sundström-Poromaa, I. (2009). Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception, 79(1), 50–55.

    Article  Google Scholar 

  • Sheng, J., Zhang, W. Y., Zhang, J. P., & Lu, D. (2009). The LNG-IUS study on adenomyosis: a three-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception, 79(3), 189–193.

    Article  Google Scholar 

  • Shivakumar, G., Bernstein, I. H., Suppes, T., Stanley Foundation Bipolar Network., Keck, P. E., McElroy, S. L., … Post, R. M. (2008). Are bipolar mood symptoms affected by the phase of the menstrual cycle? Journal Women’s Health, 17(3), 473–478.

    Google Scholar 

  • Sichel, D. A., Cohen, L. S., Robertson, L. M., Ruttenberg, A., & Rosenbaum, J. F. (1995). Prophylactic estrogen in recurrent postpartum affective disorder. Biological Psychiatry, 38(12), 814–818.

    Article  Google Scholar 

  • Sit, D., Seltman, H., & Wisner, K. L. (2011). Menstrual effects on mood symptoms in treated women with bipolar disorders. Bipolar Disorder, 13(3), 310–317.

    Article  Google Scholar 

  • Steenland, M. W., Zapata, L. B., Brahmi, D., Marchbanks, P. A., & Curtis, K. M. (2013). Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: A systematic review. Contraception, 87(5), 611–624.

    Article  Google Scholar 

  • Swaab, D. F., Boa, A. M., & Lucassen, P. J. (2005). The stress system in the human brain in depression and neurodegeneration. Ageing Research Reviews, 4(2), 141–194.

    Article  Google Scholar 

  • Taylor, A., Glover, V., Marks, M., & Kammerer, M. (2009). Diurnal pattern of cortisol output in postnatal depression. Psychoneuroendocrinology, 34, 1184–1188.

    Article  Google Scholar 

  • Timmer, C. J., & Mulders, T. M. (2000). Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clinical Pharmacokinetics, 39, 233.

    Article  Google Scholar 

  • Toffol, E., Heikinheimo, O., Koponen, P., Luoto, R., & Partonen, T. (2012). Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception, 86(5), 470–480.

    Article  Google Scholar 

  • Trussell, J., Lalla, A. M., Doan, Q. V., Reyes, E., Pinto, L., & Gricar, J. (2009). Cost effectiveness of contraceptives in the United States. Contraception, 79, 5.

    Article  Google Scholar 

  • Tsai, R., & Schaffir, J. (2010). Effect of depot medroxyprogesterone acetate on postpartum depression. Contraception, 82(2), 174–177.

    Article  Google Scholar 

  • Weaver, I. C., Cervoni, N., Champagne, F. A., D’Alessio, A. C., Sharma, S., Seckl, J. R., … Meaney, M. J. (2004) Epigenetic programming by maternal behavior. Nature Neuroscience. 7(8), 847–854.

    Google Scholar 

  • Westhoff, C., Truman, C., Kalmuss, D., Cushman, L., Davidson, A., Rulin, M., & Heartwell, S. (1998). Depressive symptoms and Depo-Provera. Contraception, 57(4), 237–240.

    Google Scholar 

  • World Health Organization. (2010). Medical eligibility criteria for contraceptive use: A WHO family planning cornerstone (4th ed.). Geneva: Switzerland.

    Google Scholar 

  • Yonkers, K., Brown, C., Pearlstein, T. B., Foegh, M., Sampson-Landers, C., & Rapkin, A. (2005). Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstetrics and Gynecology, 106(3), 492–501.

    Article  Google Scholar 

  • Young, E. A., Kornstein, S. G., Harvey, A. T., Wisniewski, S. R., Barkin, J., Fava, M., … Rush, A. J. (2007). Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology, 32(7), 843–853.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lauren Schiff M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Schiff, L. (2014). The Use of Hormonal Contraception and Its Impact on Women’s Moods. In: Barnes, D. (eds) Women's Reproductive Mental Health Across the Lifespan. Springer, Cham. https://doi.org/10.1007/978-3-319-05116-1_14

Download citation

Publish with us

Policies and ethics